Akèy › Kansè Poumon ki pa ti selil › Mississippi › Jackson
Etid klinik pou Kansè Poumon ki pa ti selil nan Jackson, MS
5 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Jackson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- University of Mississippi Medical Center, Jackson
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- University of Mississippi Medical Center, Jackson
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- Jackson Oncology Associates, PLLC, Jackson
- Jackson Oncology Associates, PLLC, Jackson
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Ap rekriteFaz 2/3
- Jackson Oncology Associates - The Hederman Cancer Center, Jackson
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- University of Mississippi Medical Center, Jackson
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Jackson
- Obèsite8 etid
- Sipwa6 etid
- Maladi fwa steatotik5 etid
- Kansè nan tete5 etid
- Ensifizyans kadyak5 etid
- Maladi selil fòs5 etid
- Kansè poumon5 etid
- Dyabèt Tip 25 etid
- Kansè pwostat5 etid
- Limfòm Burkitt4 etid
- Leksemi mieloïd egi4 etid
- Migrèn4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.